BONESUPPORT received the Frost & Sullivan 2015 Growth Capital Investment Award.
Here are four observations:
1. The award recognizes companies for achievements and superior performance in technological innovation and strategic product development in the orthopedic biomaterial market.
2. BONESUPPORT's proprietary biomaterial product, CERAMENT, is a platform technology currently available under four product lines — CERAMENT|G, CERAMENT|V, CERAMENT|BONE VOID FILLER and CERAMENT| SPINE SUPPORT.
3. CERAMENT|G and CERAMENT|V are the first CE-marked injectable bone substitutes with antibiotics indicated to promote bone healing.
4. More than 45 pre-clinical, clinical and animal studies have been conducted and more than 10,000 patients have been treated with CERAMENT, which is available in the United States, Europe, Southeast Asia and the Middle East.